Maze Therapeutics, Inc. (MAZE) stock
MAZENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$32.87−1.03 (-3.04%)
Close on Nov 17, 2026Market cap $1.83BP/E –Yield –
Maze Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Maze Therapeutics's enterprise value was $1.67B on Nov 11, 2026, against $1.43B a year earlier.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.67B | +3.6% |
| 2025 | Dec 31, 2025 | $1.61B | – |
See a number that looks wrong?